Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUPRIYA LIFESCIENCE Gains 6%; BSE HEALTHCARE Index Up 0.5%
Fri, 22 Nov 9:54

SUPRIYA LIFESCIENCE  Gains 6%; BSE HEALTHCARE Index Up 0.5%Image source: Sefa Ozel/www.istockphoto.com

SUPRIYA LIFESCIENCE share price has zoomed 6% and is presently trading at Rs 744.0.

Meanwhile, the BSE HEALTHCARE index is at 42,675.4 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are APOLLO HOSPITALS (up 2.0%) and SUN PHARMA ADV. RES. (up 1.7%).

GSK Pharma (down 0.8%) and Natco Pharma (down 0.6%) are among the top losers today.

Over the last one year, SUPRIYA LIFESCIENCE has moved up from Rs 244.0 to Rs 744.0, registering a gain of Rs 500.0 (up 204.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,583.1 to 42,675.4, registering a gain of 44.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 159.1%), SUVEN PHARMACEUTICALS (up 115.8%) and FORTIS HEALTHCARE (up 89.7%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 77,501.4 (up 0.4%).

The top gainers among the BSE Sensex today are ICICI Bank (up 1.7%) and SBI (up 1.6%). The most traded stocks in the BSE Sensex are MUNDRA PORT & SEZ and Tata Steel.

In the meantime, NSE Nifty is at 23,439.1 (up 0.4%). APOLLO HOSPITALS and ICICI Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,655.2 to 77,501.4, registering a gain of 11,846.3 points (up 18.0%).

SUPRIYA LIFESCIENCE Financial Update...

SUPRIYA LIFESCIENCE net profit grew 93.2% YoY to Rs 461 million for the quarter ended September 2024, compared to a profit of Rs 239 million a year ago. Net sales rose 18.6% to Rs 1,661 million during the period as against Rs 1,401 million in July-September 2023.

For the year ended March 2024, SUPRIYA LIFESCIENCE reported 32.6% increase in net profit to Rs 1,191 million compared to net profit of Rs 899 million during FY23. Revenue of the company grew 21.8% to Rs 4,938 million during FY24.

The current Price to earnings ratio of SUPRIYA LIFESCIENCE , based on rolling 12 month earnings, stands at 38.0.


Equitymaster requests your view! Post a comment on "SUPRIYA LIFESCIENCE Gains 6%; BSE HEALTHCARE Index Up 0.5%". Click here!